<code id='06ABE3C78C'></code><style id='06ABE3C78C'></style>
    • <acronym id='06ABE3C78C'></acronym>
      <center id='06ABE3C78C'><center id='06ABE3C78C'><tfoot id='06ABE3C78C'></tfoot></center><abbr id='06ABE3C78C'><dir id='06ABE3C78C'><tfoot id='06ABE3C78C'></tfoot><noframes id='06ABE3C78C'>

    • <optgroup id='06ABE3C78C'><strike id='06ABE3C78C'><sup id='06ABE3C78C'></sup></strike><code id='06ABE3C78C'></code></optgroup>
        1. <b id='06ABE3C78C'><label id='06ABE3C78C'><select id='06ABE3C78C'><dt id='06ABE3C78C'><span id='06ABE3C78C'></span></dt></select></label></b><u id='06ABE3C78C'></u>
          <i id='06ABE3C78C'><strike id='06ABE3C78C'><tt id='06ABE3C78C'><pre id='06ABE3C78C'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:19581
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Listen: More tumult at BIO & coercive care for sickle cell patients
          Listen: More tumult at BIO & coercive care for sickle cell patients

          Howdoesadrugindustrylobbyinggroupmoveforwardafteryearsofupheaval,includinghavingfourCEOsinfouryears?

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Dexcom's push to bring CGM to type 2 diabetes patients

          KevinSayer,CEOofDexcomDexcomForyears,diabetestechcompanyDexcomhasbeenstrivingtogetitscontinuousgluco